APO Research
Talk to an analyst

APO RESEARCH · REPORT

Complement C5 Recombinant Monoclonal Antibody

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Complement C5 Recombinant Monoclonal Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025188 pages

Choose your research edition.

Industry ResearchComplement C5 Recombinant Monoclonal Antibody Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Complement C5 Recombinant Monoclonal Antibody Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Complement C5 Recombinant Monoclonal Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Complement C5 Recombinant Monoclonal Antibody Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Complement C5 Recombinant Monoclonal Antibody Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Complement C5 Recombinant Monoclonal Antibody market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Complement C5 Recombinant Monoclonal Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Complement C5 Recombinant Monoclonal Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Complement C5 Recombinant Monoclonal Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Complement C5 Recombinant Monoclonal Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Complement C5 Recombinant Monoclonal Antibody include Alexion Pharmaceuticals, Regeneron Pharmaceuticals, Amgen, Roche and Samsung Bioepis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Complement C5 Recombinant Monoclonal Antibody market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Complement C5 Recombinant Monoclonal Antibody and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Complement C5 Recombinant Monoclonal Antibody sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Complement C5 Recombinant Monoclonal Antibody market size, projected growth trends, production technologies, key applications, and end-use industries.

Complement C5 Recombinant Monoclonal Antibody Segment by Company

Alexion Pharmaceuticals

Regeneron Pharmaceuticals

Amgen

Roche

Samsung Bioepis

Complement C5 Recombinant Monoclonal Antibody Segment by Type

Eculizumab

Pozelimab

Ravulizumab

Crovalimab

Others

Complement C5 Recombinant Monoclonal Antibody Segment by Application

PNH

CD55 Deficiency

aHUS

Others

Complement C5 Recombinant Monoclonal Antibody Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Complement C5 Recombinant Monoclonal Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Complement C5 Recombinant Monoclonal Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Complement C5 Recombinant Monoclonal Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Complement C5 Recombinant Monoclonal Antibody market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Complement C5 Recombinant Monoclonal Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Complement C5 Recombinant Monoclonal Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Complement C5 Recombinant Monoclonal Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Complement C5 Recombinant Monoclonal Antibody Industry Trends Table 2. Complement C5 Recombinant Monoclonal Antibody Industry Drivers Table 3. Complement C5 Recombinant Monoclonal Antibody Industry Opportunities and Challenges Table 4. Complement C5 Recombinant Monoclonal Antibody Industry Restraints Table 5. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Complement C5 Recombinant Monoclonal Antibody Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Manufacturers Table 9. Global Complement C5 Recombinant Monoclonal Antibody Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Complement C5 Recombinant Monoclonal Antibody Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Complement C5 Recombinant Monoclonal Antibody Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Complement C5 Recombinant Monoclonal Antibody Manufacturers, Product Type & Application Table 13. Global Complement C5 Recombinant Monoclonal Antibody Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Complement C5 Recombinant Monoclonal Antibody by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Eculizumab Table 17. Major Manufacturers of Pozelimab Table 18. Major Manufacturers of Ravulizumab Table 19. Major Manufacturers of Crovalimab Table 20. Major Manufacturers of Others Table 21. Global Complement C5 Recombinant Monoclonal Antibody Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (K Units) Table 23. Global Complement C5 Recombinant Monoclonal Antibody Sales by Type (2027-2032) & (K Units) Table 24. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Type (2021-2026) Table 25. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Type (2027-2032) Table 26. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021-2026) & (K Units) Table 28. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2027-2032) & (K Units) Table 29. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Type (2021-2026) Table 30. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of PNH Table 32. Major Manufacturers of CD55 Deficiency Table 33. Major Manufacturers of aHUS Table 34. Major Manufacturers of Others Table 35. Global Complement C5 Recombinant Monoclonal Antibody Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (K Units) Table 37. Global Complement C5 Recombinant Monoclonal Antibody Sales by Application (2027-2032) & (K Units) Table 38. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Application (2021-2026) Table 39. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Application (2027-2032) Table 40. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 41. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021-2026) & (K Units) Table 42. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2027-2032) & (K Units) Table 43. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Application (2021-2026) Table 44. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Application (2027-2032) Table 45. Global Complement C5 Recombinant Monoclonal Antibody Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Complement C5 Recombinant Monoclonal Antibody Sales by Region (2021-2026) & (K Units) Table 47. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Region (2021-2026) Table 48. Global Complement C5 Recombinant Monoclonal Antibody Sales Forecasted by Region (2027-2032) & (K Units) Table 49. Global Complement C5 Recombinant Monoclonal Antibody Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Complement C5 Recombinant Monoclonal Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. North America Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026) & (K Units) Table 52. North America Complement C5 Recombinant Monoclonal Antibody Sales by Country (2027-2032) & (K Units) Table 53. Europe Complement C5 Recombinant Monoclonal Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026) & (K Units) Table 55. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Country (2027-2032) & (K Units) Table 56. Asia Pacific Complement C5 Recombinant Monoclonal Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Asia Pacific Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026) & (K Units) Table 58. Asia Pacific Complement C5 Recombinant Monoclonal Antibody Sales by Country (2027-2032) & (K Units) Table 59. South America, Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. South America, Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026) & (K Units) Table 61. South America, Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales by Country (2027-2032) & (K Units) Table 62. Global Complement C5 Recombinant Monoclonal Antibody Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Region (2021-2026) Table 66. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Region (2027-2032) Table 67. Alexion Pharmaceuticals Company Information Table 68. Alexion Pharmaceuticals Business Overview Table 69. Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product Portfolio Table 71. Alexion Pharmaceuticals Recent Development Table 72. Regeneron Pharmaceuticals Company Information Table 73. Regeneron Pharmaceuticals Business Overview Table 74. Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product Portfolio Table 76. Regeneron Pharmaceuticals Recent Development Table 77. Amgen Company Information Table 78. Amgen Business Overview Table 79. Amgen Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Amgen Complement C5 Recombinant Monoclonal Antibody Product Portfolio Table 81. Amgen Recent Development Table 82. Roche Company Information Table 83. Roche Business Overview Table 84. Roche Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Roche Complement C5 Recombinant Monoclonal Antibody Product Portfolio Table 86. Roche Recent Development Table 87. Samsung Bioepis Company Information Table 88. Samsung Bioepis Business Overview Table 89. Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Product Portfolio Table 91. Samsung Bioepis Recent Development Table 92. Key Raw Materials Table 93. Raw Materials Key Suppliers Table 94. Complement C5 Recombinant Monoclonal Antibody Distributors List Table 95. Complement C5 Recombinant Monoclonal Antibody Customers List Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Complement C5 Recombinant Monoclonal Antibody Product Image Figure 2. Global Complement C5 Recombinant Monoclonal Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Complement C5 Recombinant Monoclonal Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global Complement C5 Recombinant Monoclonal Antibody Sales (2021-2032) & (K Units) Figure 5. Global Complement C5 Recombinant Monoclonal Antibody Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Complement C5 Recombinant Monoclonal Antibody Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Eculizumab Image Figure 9. Pozelimab Image Figure 10. Ravulizumab Image Figure 11. Crovalimab Image Figure 12. Others Image Figure 13. Global Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Type (2021-2032) Figure 16. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Type (2021-2032) Figure 19. PNH Image Figure 20. CD55 Deficiency Image Figure 21. aHUS Image Figure 22. Others Image Figure 23. Global Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Application (2021-2032) Figure 26. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Application (2021-2032) Figure 29. North America Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 30. North America Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country (2021-2032) Figure 31. U.S. Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Canada Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Mexico Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country (2021-2032) Figure 36. Germany Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 37. France Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 38. U.K. Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Italy Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Netherlands Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country (2021-2032) Figure 43. China Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Japan Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South Korea Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Southeast Asia Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 47. India Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Australia Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country (2021-2032) Figure 51. Brazil Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South Africa Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Saudi Arabia Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Turkey Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Argentina Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 56. UAE Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Egypt Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Chile Complement C5 Recombinant Monoclonal Antibody Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Global Complement C5 Recombinant Monoclonal Antibody Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Figure 62. North America Complement C5 Recombinant Monoclonal Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Figure 64. Europe Complement C5 Recombinant Monoclonal Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Complement C5 Recombinant Monoclonal Antibody Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Complement C5 Recombinant Monoclonal Antibody Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Eculizumab
  • Pozelimab
  • Ravulizumab
  • Crovalimab
  • Others
Applications
  • PNH
  • CD55 Deficiency
  • aHUS
  • Others
Companies covered
  • Alexion Pharmaceuticals
  • Regeneron Pharmaceuticals
  • Amgen
  • Roche
  • Samsung Bioepis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Complement C5 Recombinant Monoclonal Antibody Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Complement C5 Recombinant Monoclonal Antibody Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Complement C5 Recombinant Monoclonal Antibody Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Complement C5 Recombinant Monoclonal Antibody Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Complement C5 Recombinant Monoclonal Antibody Market Dynamics
  1. 2.1 Complement C5 Recombinant Monoclonal Antibody Industry Trends
  2. 2.2 Complement C5 Recombinant Monoclonal Antibody Industry Drivers
  3. 2.3 Complement C5 Recombinant Monoclonal Antibody Industry Opportunities and Challenges
  4. 2.4 Complement C5 Recombinant Monoclonal Antibody Industry Restraints
3 Complement C5 Recombinant Monoclonal Antibody Market by Manufacturers
  1. 3.1 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Complement C5 Recombinant Monoclonal Antibody Sales by Manufacturers (2021-2026)
  3. 3.3 Global Complement C5 Recombinant Monoclonal Antibody Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Complement C5 Recombinant Monoclonal Antibody Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Complement C5 Recombinant Monoclonal Antibody Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Complement C5 Recombinant Monoclonal Antibody Manufacturers, Product Type & Application
  7. 3.7 Global Complement C5 Recombinant Monoclonal Antibody Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Complement C5 Recombinant Monoclonal Antibody Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Complement C5 Recombinant Monoclonal Antibody Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Complement C5 Recombinant Monoclonal Antibody Tier 1, Tier 2, and Tier 3
4 Complement C5 Recombinant Monoclonal Antibody Market by Type
  1. 4.1 Complement C5 Recombinant Monoclonal Antibody Type Introduction
  2. 4.1.1 Eculizumab
  3. 4.1.2 Pozelimab
  4. 4.1.3 Ravulizumab
  5. 4.1.4 Crovalimab
  6. 4.1.5 Others
  7. 4.2 Global Complement C5 Recombinant Monoclonal Antibody Sales by Type
  8. 4.2.1 Global Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2032)
  10. 4.2.3 Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Type (2021-2032)
  11. 4.3 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Type
  12. 4.3.1 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021-2032)
  14. 4.3.3 Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Type (2021-2032)
5 Complement C5 Recombinant Monoclonal Antibody Market by Application
  1. 5.1 Complement C5 Recombinant Monoclonal Antibody Application Introduction
  2. 5.1.1 PNH
  3. 5.1.2 CD55 Deficiency
  4. 5.1.3 aHUS
  5. 5.1.4 Others
  6. 5.2 Global Complement C5 Recombinant Monoclonal Antibody Sales by Application
  7. 5.2.1 Global Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2032)
  9. 5.2.3 Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Application (2021-2032)
  10. 5.3 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Application
  11. 5.3.1 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021-2032)
  13. 5.3.3 Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Application (2021-2032)
6 Global Complement C5 Recombinant Monoclonal Antibody Sales by Region
  1. 6.1 Global Complement C5 Recombinant Monoclonal Antibody Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Complement C5 Recombinant Monoclonal Antibody Sales by Region (2021-2032)
  3. 6.2.1 Global Complement C5 Recombinant Monoclonal Antibody Sales by Region (2021-2026)
  4. 6.2.2 Global Complement C5 Recombinant Monoclonal Antibody Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Complement C5 Recombinant Monoclonal Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Complement C5 Recombinant Monoclonal Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Complement C5 Recombinant Monoclonal Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Region
  1. 7.1 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Region
  2. 7.1.1 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Region (2021-2026)
  4. 7.1.3 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Region (2027-2032)
  5. 7.1.4 Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032)
  8. 7.2.2 North America Complement C5 Recombinant Monoclonal Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032)
  11. 7.3.2 Europe Complement C5 Recombinant Monoclonal Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Complement C5 Recombinant Monoclonal Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alexion Pharmaceuticals
  2. 8.1.1 Alexion Pharmaceuticals Company Information
  3. 8.1.2 Alexion Pharmaceuticals Business Overview
  4. 8.1.3 Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product Portfolio
  6. 8.1.5 Alexion Pharmaceuticals Recent Developments
  7. 8.2 Regeneron Pharmaceuticals
  8. 8.2.1 Regeneron Pharmaceuticals Company Information
  9. 8.2.2 Regeneron Pharmaceuticals Business Overview
  10. 8.2.3 Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product Portfolio
  12. 8.2.5 Regeneron Pharmaceuticals Recent Developments
  13. 8.3 Amgen
  14. 8.3.1 Amgen Company Information
  15. 8.3.2 Amgen Business Overview
  16. 8.3.3 Amgen Complement C5 Recombinant Monoclonal Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Amgen Complement C5 Recombinant Monoclonal Antibody Product Portfolio
  18. 8.3.5 Amgen Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche Complement C5 Recombinant Monoclonal Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roche Complement C5 Recombinant Monoclonal Antibody Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 Samsung Bioepis
  26. 8.5.1 Samsung Bioepis Company Information
  27. 8.5.2 Samsung Bioepis Business Overview
  28. 8.5.3 Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Product Portfolio
  30. 8.5.5 Samsung Bioepis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Complement C5 Recombinant Monoclonal Antibody Value Chain Analysis
  2. 9.1.1 Complement C5 Recombinant Monoclonal Antibody Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Complement C5 Recombinant Monoclonal Antibody Production Mode & Process
  6. 9.2 Complement C5 Recombinant Monoclonal Antibody Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Complement C5 Recombinant Monoclonal Antibody Distributors
  9. 9.2.3 Complement C5 Recombinant Monoclonal Antibody Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst